Form 4 for TMDX TransMedics Group, Inc.
Accepted 2022-10-04 00:00:00 ET · period of report 2022-10-03 · accession 0000899243-22-032662 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-04 | 2022-10-03 | TMDX | Gordon Stephen | CFO | S - Sale+OE | $41.74 | -10.0K | 5,714 | -64% | -$417.4K |
| D | 2022-10-04 | 2022-10-03 | TMDX | Gordon Stephen | CFO | M - OptEx | $2.21 | +10.0K | 15.7K | +175% | +$22.1K |
| D | 2022-10-04 | 2022-10-03 | TMDX | Gordon Stephen | CFO | M - OptEx | $0.00 | -10.0K | 728 | -93% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-03 | S | D | 10,000 | $41.74 | 5,714 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-03 | M | A | 10,000 | $2.21 | 15,714 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-10-03 | M | D | 10,000 | $0.00 | 728 | D | $2.21 · — to 2027-06-22 | 10,000 Common Stock | (F2) The option is fully vested. |